256 related articles for article (PubMed ID: 36377878)
21. Immune responses induced by replication-defective adenovirus expressing the C-terminal portion of the Mycoplasma hyopneumoniae P97 adhesin.
Okamba FR; Moreau E; Cheikh Saad Bouh K; Gagnon CA; Massie B; Arella M
Clin Vaccine Immunol; 2007 Jun; 14(6):767-74. PubMed ID: 17409219
[TBL] [Abstract][Full Text] [Related]
22. Salmonella enterica serovar Choleraesuis vector delivering SaoA antigen confers protection against Streptococcus suis serotypes 2 and 7 in mice and pigs.
Li YA; Ji Z; Wang X; Wang S; Shi H
Vet Res; 2017 Dec; 48(1):89. PubMed ID: 29268787
[TBL] [Abstract][Full Text] [Related]
23. Development of a Multi-Epitope Vaccine for
Li G; Shu J; Jin J; Shu J; Feng H; Chen J; He Y
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887246
[No Abstract] [Full Text] [Related]
24. Vaccine efficacy of the attenuated Erysipelothrix rhusiopathiae YS-19 expressing a recombinant protein of Mycoplasma hyopneumoniae P97 adhesin against mycoplasmal pneumonia of swine.
Shimoji Y; Oishi E; Muneta Y; Nosaka H; Mori Y
Vaccine; 2003 Jan; 21(5-6):532-7. PubMed ID: 12531653
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity of IMS 1113 plus soluble subunit and chimeric proteins containing Mycoplasma hyopneumoniae P97 C-terminal repeat regions.
Barate AK; Cho Y; Truong QL; Hahn TW
FEMS Microbiol Lett; 2014 Mar; 352(2):213-20. PubMed ID: 24461070
[TBL] [Abstract][Full Text] [Related]
26. Immunisation of mice with Mycoplasma hyopneumoniae antigens P37, P42, P46 and P95 delivered as recombinant subunit or DNA vaccines.
Galli V; Simionatto S; Marchioro SB; Fisch A; Gomes CK; Conceição FR; Dellagostin OA
Vaccine; 2012 Dec; 31(1):135-40. PubMed ID: 23137841
[TBL] [Abstract][Full Text] [Related]
27. A concise review of vaccines against Mycoplasma hyopneumoniae.
Tao Y; Shu J; Chen J; Wu Y; He Y
Res Vet Sci; 2019 Apr; 123():144-152. PubMed ID: 30665029
[TBL] [Abstract][Full Text] [Related]
28. Effects of Mycoplasma hyopneumoniae on porcine nasal cavity dendritic cells.
Shen Y; Hu W; Wei Y; Feng Z; Yang Q
Vet Microbiol; 2017 Jan; 198():1-8. PubMed ID: 28061998
[TBL] [Abstract][Full Text] [Related]
29. Comparative immunogenicity of M. hyopneumoniae NrdF encoded in different expression systems delivered orally via attenuated S. typhimurium aroA in mice.
Chen AY; Fry SR; Forbes-Faulkner J; Daggard GE; Mukkur TK
Vet Microbiol; 2006 May; 114(3-4):252-9. PubMed ID: 16426773
[TBL] [Abstract][Full Text] [Related]
30. Efficacy evaluation of a novel oral silica-based vaccine in inducing mucosal immunity against Mycoplasma hyopneumoniae.
Ferreira GC; Sanches TVC; Mechler-Dreibi ML; Almeida HMS; Storino GY; Sonalio K; Petri FAM; Martins TS; Cides da Silva LC; Montassier HJ; Sant'Anna OA; Fantini MCA; de Oliveira LG
Res Vet Sci; 2023 May; 158():141-150. PubMed ID: 37004428
[TBL] [Abstract][Full Text] [Related]
31. Oral immunization of mice with attenuated Salmonella typhimurium aroA expressing a recombinant Mycoplasma hyopneumoniae antigen (NrdF).
Fagan PK; Djordjevic SP; Chin J; Eamens GJ; Walker MJ
Infect Immun; 1997 Jun; 65(6):2502-7. PubMed ID: 9169801
[TBL] [Abstract][Full Text] [Related]
32. Immune responses of a chimaeric protein vaccine containing Mycoplasma hyopneumoniae antigens and LTB against experimental M. hyopneumoniae infection in pigs.
Marchioro SB; Sácristan Rdel P; Michiels A; Haesebrouck F; Conceição FR; Dellagostin OA; Maes D
Vaccine; 2014 Aug; 32(36):4689-94. PubMed ID: 24909331
[TBL] [Abstract][Full Text] [Related]
33. Live-attenuated Salmonella enterica serotype Choleraesuis vaccine with regulated delayed fur mutation confer protection against Streptococcus suis in mice.
Li YA; Chen Y; Du YZ; Guo W; Chu D; Fan J; Wang X; Bellefleur M; Wang S; Shi H
BMC Vet Res; 2020 May; 16(1):129. PubMed ID: 32381017
[TBL] [Abstract][Full Text] [Related]
34. A recombinant chimera composed of R1 repeat region of Mycoplasma hyopneumoniae P97 adhesin with Escherichia coli heat-labile enterotoxin B subunit elicits immune response in mice.
Conceição FR; Moreira AN; Dellagostin OA
Vaccine; 2006 Jul; 24(29-30):5734-43. PubMed ID: 16730864
[TBL] [Abstract][Full Text] [Related]
35. Live attenuated Salmonella enterica serovar Choleraesuis vector delivering a virus-like particles induces a protective immune response against porcine circovirus type 2 in mice.
Li YA; Sun Y; Zhang Y; Wang S; Shi H
Vaccine; 2022 Aug; 40(33):4732-4741. PubMed ID: 35773121
[TBL] [Abstract][Full Text] [Related]
36. Co-administration of attenuated Mycoplasma hyopneumoniae 168 strain with bacterial DNA enhances the local and systemic immune response after intranasal vaccination in pigs.
Li Y; Li P; Wang X; Yu Q; Yang Q
Vaccine; 2012 Mar; 30(12):2153-8. PubMed ID: 22266290
[TBL] [Abstract][Full Text] [Related]
37. Oral vaccination against mycoplasmal pneumonia of swine using a live Erysipelothrix rhusiopathiae vaccine strain as a vector.
Ogawa Y; Oishi E; Muneta Y; Sano A; Hikono H; Shibahara T; Yagi Y; Shimoji Y
Vaccine; 2009 Jul; 27(33):4543-50. PubMed ID: 19433128
[TBL] [Abstract][Full Text] [Related]
38. A recombinant chimera comprising the R1 and R2 repeat regions of M. hyopneumoniae P97 and the N-terminal region of A. pleuropneumoniae ApxIII elicits immune responses.
Lee SH; Lee S; Chae C; Ryu DY
BMC Vet Res; 2014 Feb; 10():43. PubMed ID: 24533486
[TBL] [Abstract][Full Text] [Related]
39. Protective immunity induced by concurrent intradermal injection of porcine circovirus type 2 and Mycoplasma hyopneumoniae inactivated vaccines in pigs.
Lee SI; Jeong CG; Ul Salam Mattoo S; Nazki S; Prasad Aganja R; Kim SC; Khatun A; Oh Y; Noh SH; Lee SM; Kim WI
Vaccine; 2021 Oct; 39(45):6691-6699. PubMed ID: 34538524
[TBL] [Abstract][Full Text] [Related]
40. [Construction of the recombinant adenovirus expressing the C-terminal of the Mycoplasma hyopneumoniae p97 gene and its immune response].
Chen C; Li Y; Guo D; Cao P; Zhang M; Jiang H; Qiao Z; Wang L; Xin J
Wei Sheng Wu Xue Bao; 2009 Apr; 49(4):465-70. PubMed ID: 19621633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
